Molindone

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Molindone
Molindone.svg
Systematic (IUPAC) name
3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-
1,5,6,7-tetrahydro-4H-indol-4-one
Clinical data
Trade names Moban
AHFS/Drugs.com Consumer Drug Information
MedlinePlus a682238
Pregnancy
category
  • C
Legal status
  • ℞ (Prescription only)
Routes of
administration
Oral
Pharmacokinetic data
Metabolism Hepatic
Biological half-life 1.5 hours
Excretion Minor, renal and fecal
Identifiers
CAS Number 7416-34-4 YesY
ATC code N05AE02 (WHO)
PubChem CID: 23897
IUPHAR/BPS 207
DrugBank DB01618 N
ChemSpider 22342 YesY
UNII RT3Y3QMF8N YesY
KEGG D08226 YesY
ChEMBL CHEMBL460 YesY
Chemical data
Formula C16H24N2O2
Molecular mass 276.374 g/mol
  • O=C2c1c(c(nc1CCC2CN3CCOCC3)C)CC
  • InChI=1S/C16H24N2O2/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18/h12,17H,3-10H2,1-2H3 YesY
  • Key:KLPWJLBORRMFGK-UHFFFAOYSA-N YesY
 NYesY (what is this?)  (verify)

Molindone (Moban) is a therapeutic antipsychotic, used in the treatment of schizophrenia.[1] It works by blocking the effects of dopamine in the brain, leading to diminished psychoses. It is rapidly absorbed when taken orally.

It is sometimes described as a typical antipsychotic,[2] and sometimes described as an atypical antipsychotic.[3]

Molindone was discontinued by its sole supplier, Endo Pharmaceuticals, on January 13, 2010. [4]

Adverse effects

<templatestyles src="Module:Hatnote/styles.css"></templatestyles>

The side effect profile of molindone is similar to that of other typical antipsychotics. Unlike most antipsychotics, however, molindone use is associated with weight loss.[3][5]

Synthesis

Molindone synthesis: SCHOEN KARL, J PACHTER IRWIN; BE 670798  (1965 to Endo Lab).

Condensation of oximinoketone 2 (from nitrosation of 3-pentanone), with 1,3-Cyclohexanedione (1) in the presenec of zinc and acetic acid leads directly to the partly reduced indole derivative 6. The transformation may be rationalized by assuming as the first step, reduction of 2 to the corresponding α-aminoketone. Conjugate addition of the amine to 1 followed by elimination of hydroxide (as water) would give ene-aminoketone 3. This enamine may be assumed to be in tautomeric equilibrium with imine 4. Aldol condensation of the side chain carbonyl group with the doubly activated ring methylene[disambiguation needed] would then result in cyclization to pyrrole 5; simple tautomeric transformation would then give the observed product. Mannich reaction of 6 with formaldehyde and morpholine gives the tranquilizer molindone (7).

See also

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. Lua error in package.lua at line 80: module 'strict' not found.
  3. 3.0 3.1 Lua error in package.lua at line 80: module 'strict' not found.
  4. http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050794.htm
  5. Lua error in package.lua at line 80: module 'strict' not found. Free full text